0001144204-18-009165.txt : 20180215 0001144204-18-009165.hdr.sgml : 20180215 20180215080023 ACCESSION NUMBER: 0001144204-18-009165 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180215 DATE AS OF CHANGE: 20180215 EFFECTIVENESS DATE: 20180215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tremeau Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001722110 IRS NUMBER: 813327223 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-305704 FILM NUMBER: 18616178 BUSINESS ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 6176748196 MAIL ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0708 D LIVE 0001722110 Tremeau Pharmaceuticals, Inc. ONE BROADWAY 14TH FLOOR CAMBRIDGE MA MASSACHUSETTS 02142 6176748196 DELAWARE None None Corporation true 2016 Bradford C. Sippy One Broadway 14th Floor Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Mark Corrigan One Broadway 14th Floor Cambridge MA MASSACHUSETTS 02142 Executive Officer Benjamin Enerson One Broadway 14th Floor Cambridge MA MASSACHUSETTS 02142 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2016-10-17 false true true false 10000 5196001 5196001 0 Offering and sales amounts consist of (i) common stock investments of $4,186,001 and (ii) convertible note investments (all of which have converted to common stock) with an aggregate principal amount of $1,010,000. true 4 59 0 0 0 false Tremeau Pharmaceuticals, Inc. /s/ Bradford C. Sippy Bradford C. Sippy CEO 2018-02-14